IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (35)
Bank of America Merrill Lynch
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 12 | Bill.com Holdin | Technology | 22 | 9 | GS | BAML | JEFF | 97% | 61.4% | ||
Nov 11 | 89bio Inc. | Health-Care | 16 | 5 | BAML | LRNK | RBC | 4.6% | 30% | ||
Nov 7 | Galera Therapeu | Health-Care | 12 | 5 | BAML | CITI | CS | 26.3% | 0% | ||
Oct 25 | Progyny Inc. | Health-Care | 13 | 10 | JPM | GS | BAML | 49.7% | 22.6% | ||
Oct 24 | BRP Group Inc. | Finance | 14 | 16 | JPM | BAML | 40.9% | 16.9% | |||
Oct 10 | BioNTech SE | Health-Care | 15 | 10 | JPM | BAML | UBS | 28.1% | -5.1% | ||
Sep 19 | Ping Identity H | Technology | 15 | 12 | GS | BAML | RBC | 91.9% | 34.1% | ||
Sep 12 | SmileDirectClub | Health-Care | 23 | 58 | JPM | CITI | BAML | 81.6% | -24.9% | ||
Sep 12 | 10x Genomics In | Health-Care | 39 | 10 | JPM | GS | BAML | 73.3% | 35.3% | ||
Jul 25 | Sunnova Energy | Consumer-Services | 12 | 14 | BAML | JPM | GS | 32.4% | -6.3% | ||
Jul 19 | Intercorp Finan | Finance | 46 | 9 | BAML | JPM | 27.2% | 2.2% | |||
Jul 19 | Afya Limited | Consumer-Services | 19 | 13 | BAML | GS | UBS | 53.5% | 25.5% | ||
Jul 18 | Genmab A/S | Health-Care | 17.8 | 28 | BAML | MS | JEFF | 20.7% | 1.4% | ||
Jul 18 | Fulcrum Therape | Health-Care | 16 | 4 | MS | BAML | LRNK | 27.6% | -15.6% | ||
Jul 17 | DouYu Internati | Technology | 11.5 | 67 | MS | JPM | BAML | 48.4% | 0% | ||
Jun 28 | The RealReal In | NA | 20 | 15 | CS | BAML | UBS | 131.1% | 44.5% | ||
Jun 27 | Adaptive Biotec | NA | 20 | 15 | GS | JPM | BAML | 75% | 101.5% | ||
Jun 20 | Personalis Inc. | NA | 17 | 7 | MS | BAML | COWN | 79% | 67.6% | ||
Jun 20 | Grocery Outlet | NA | 22 | 17 | BAML | MS | DB | 77.9% | 29.6% | ||
Jun 12 | CrowdStrike Hol | NA | 34 | 18 | GS | JPM | BAML | 107.9% | 70.6% | ||
Jun 7 | Revolve Group I | NA | 18 | 11 | MS | CS | BAML | 160.6% | 88.9% | ||
May 23 | Rattler Midstre | NA | 17.5 | 38 | CS | BAML | JPM | 40.5% | 9.9% | ||
May 17 | Fastly Inc. | NA | 16 | 11 | BAML | CS | CITI | 141.9% | 49.9% | ||
May 17 | Avantor Inc. | NA | 14 | 207 | GS | JPM | BAML | 18.9% | 3.6% | ||
May 10 | Uber Technologi | Transportation | 45 | 180 | MS | GS | BAML | 103.5% | -7.6% | ||
May 9 | NextCure Inc. | NA | 15 | 5 | MS | BAML | PPRJ | 32.9% | 32.7% | ||
May 9 | Cortexyme Inc. | NA | 17 | 4 | BAML | CS | 30.6% | 93.5% | |||
May 8 | Parsons Corpora | NA | 27 | 18 | GS | BAML | MS | 80% | 11.4% | ||
May 3 | SciPlay Corpora | NA | 16 | 22 | BAML | JPM | DB | 79.1% | -4.7% | ||
Apr 18 | HOOKIPA Pharma | NA | 14 | 6 | BAML | RBC | 26.6% | 0% | |||
Apr 4 | Silk Road Medic | NA | 20 | 6 | JPM | BAML | 98.4% | 80.9% | |||
Mar 7 | ShockWave Medic | NA | 17 | 5 | MS | BAML | 55.5% | 79.4% | |||
Feb 14 | Avedro Inc | NA | 14 | 5 | BAML | JPM | 68.2% | -11.8% | |||
Feb 8 | Gossamer Bio In | NA | 16 | 17 | BAML | LRNK | BRCL | 34.2% | 12.1% | ||
Feb 7 | Alector Inc. | NA | 19 | 9 | MS | BAML | COWN | 39.2% | -4.8% |
*
Lead manager or one of top three managers in an underwriting team.